| Mrs Donna M Klawinski, MS CCCA | |
|
2741 W Layton Avenue Suite 206, Milwaukee, WI 53221-2600 | |
| (414) 281-9820 | |
| (414) 281-9835 |
| Full Name | Mrs Donna M Klawinski |
|---|---|
| Gender | Female |
| Speciality | Qualified Audiologist |
| Experience | 40 Years |
| Location | 2741 W Layton Avenue Suite 206, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033208210 | NPI | - | NPPES |
| 41111200 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 166156 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Martin E Samuel Dds Md Sc | 8123176690 | 2 |
News Archive
In patients with type 2 diabetes, big swings in blood sugar levels between doctors' visits are associated with an increased risk of heart disease.
Regulus Therapeutics Inc. announced today that it has obtained exclusive rights from the University of Wuerzburg to intellectual property covering methods for modulating microRNA-21. Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting miR-21 inhibits fibrosis and attenuates cardiac function in such models. Regulus is currently developing a microRNA therapeutic targeting miR-21 as an anti-fibrotic therapy.
By activating particular neurons, we may be able to influence alcohol drinking behavior, according to new findings published by researchers at the Texas A&M Health Science Center College of Medicine in the journal Biological Psychiatry.
New University of Georgia research has found that a statin drug that is often known by the brand-name Lipitor may help prevent blindness in people with diabetes.
Researchers have created a new drug delivery system that could improve the effectiveness of an emerging concept in cancer treatment - to dramatically slow and control tumors on a long-term, sustained basis, not necessarily aiming for their complete elimination.
› Verified 3 days ago
| Provider Name | Martin E Samuel Dds Md Sc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1255582078 PECOS PAC ID: 8123176690 Enrollment ID: O20090511000581 |
News Archive
In patients with type 2 diabetes, big swings in blood sugar levels between doctors' visits are associated with an increased risk of heart disease.
Regulus Therapeutics Inc. announced today that it has obtained exclusive rights from the University of Wuerzburg to intellectual property covering methods for modulating microRNA-21. Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting miR-21 inhibits fibrosis and attenuates cardiac function in such models. Regulus is currently developing a microRNA therapeutic targeting miR-21 as an anti-fibrotic therapy.
By activating particular neurons, we may be able to influence alcohol drinking behavior, according to new findings published by researchers at the Texas A&M Health Science Center College of Medicine in the journal Biological Psychiatry.
New University of Georgia research has found that a statin drug that is often known by the brand-name Lipitor may help prevent blindness in people with diabetes.
Researchers have created a new drug delivery system that could improve the effectiveness of an emerging concept in cancer treatment - to dramatically slow and control tumors on a long-term, sustained basis, not necessarily aiming for their complete elimination.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Donna M Klawinski, MS CCCA 2741 W Layton Avenue Suite 206, Milwaukee, WI 53221-2600 Ph: (414) 281-9820 | Mrs Donna M Klawinski, MS CCCA 2741 W Layton Avenue Suite 206, Milwaukee, WI 53221-2600 Ph: (414) 281-9820 |
News Archive
In patients with type 2 diabetes, big swings in blood sugar levels between doctors' visits are associated with an increased risk of heart disease.
Regulus Therapeutics Inc. announced today that it has obtained exclusive rights from the University of Wuerzburg to intellectual property covering methods for modulating microRNA-21. Regulus scientists and collaborators have shown that microRNA-21, (miR-21), is dysregulated in mouse models of cardiac disease and fibrosis, and that antagonizing miR-21 with therapeutic oligonucleotides targeting miR-21 inhibits fibrosis and attenuates cardiac function in such models. Regulus is currently developing a microRNA therapeutic targeting miR-21 as an anti-fibrotic therapy.
By activating particular neurons, we may be able to influence alcohol drinking behavior, according to new findings published by researchers at the Texas A&M Health Science Center College of Medicine in the journal Biological Psychiatry.
New University of Georgia research has found that a statin drug that is often known by the brand-name Lipitor may help prevent blindness in people with diabetes.
Researchers have created a new drug delivery system that could improve the effectiveness of an emerging concept in cancer treatment - to dramatically slow and control tumors on a long-term, sustained basis, not necessarily aiming for their complete elimination.
› Verified 3 days ago
Dr. Kya Elizabeth Hulse, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 9000 W Wisconsin Ave # B340, Milwaukee, WI 53226 Phone: 414-266-2934 | |
Dr. Christina L Runge, PHD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 9200 W Wisconsin Ave, Otolaryngology, Milwaukee, WI 53226 Phone: 414-805-5562 Fax: 414-805-7936 | |
Dr. Brooke Eileen Flesher, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 9000 W Wisconsin Ave Ste B340, Milwaukee, WI 53226 Phone: 414-266-5725 Fax: 414-266-6189 | |
Casey Wolter, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 9000 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-266-2934 Fax: 414-266-6189 | |
Rachel Ann Lynch, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 9000 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-266-2934 | |
Mr. John G Knox, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 9200 W Wisconsin Ave, Milwaukee, WI 53226 Phone: 414-805-3666 |